Author(s): Emily J Culme-Seymour [*] 1 , Chris Mason 2
cell therapy; glossary; harmonization; regenerative medicine; regulation; standards
Regenerative medicine and cell therapy are rapidly becoming global multibillion dollar healthcare sectors  . Both are unique and disruptive to established treatment regimens, medical practices and healthcare business models [1-3] . The medical specialty of regenerative medicine and the platform technology of living cells as therapies have many of their own unique challenges; however, the need for harmonization across national and international boundaries is an issue that faces them both. Thus, all the respective parties from both sectors need to be able to properly communicate their ideas, opinions and solutions, and interact with ease. This is especially demanding given the large numbers of diverse direct stakeholder groups involved in both sectors, including patients, the general public, politicians, scientists, engineers, clinicians, industrial workers, regulators and funders, not to mention all the indirect enablers (i.e., patent lawyers, tools and reagent manufacturers, and storage and distribution companies - to name but a few). There is, therefore, a very real and urgent need for an up-to-date, high-quality, consensus-driven glossary of essential specialist terms.
The first glossary in the regenerative medicine field was masterminded by the British Standards Institution (BSI) in 2008 under the very capable management of Alex Kay (Project Manager, BSI). To greatly increase awareness along with its availability and hence its impact,...